Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
Moderate quality score of 54/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street sentiment is generally neutral. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
GAM demonstrates adequate business quality with stable profitability. This is paired with a moderately leveraged but stable balance sheet.
The company maintains stable top-line performance however, earnings have severely contracted over the same period. The company maintains healthy operational efficiency with a 21.3% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $6.3M | +180.6% | — | — | +26.8% | |
| EBITDA | -$1.8M | — | -5.7% | — | — | |
| Net Income | $75.2M | -10.2% | -5.8% | — | +13.0% | |
| EPS (Diluted) | $3.11 | -36.1% | -13.7% | -7.9% | +16.5% | |
| Free Cash Flow | $0.00 | — | — | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 100.0% | 97.1% | 132.2% | 114.0% |
| Operating Margin | 21.3% | 170.0% | 173.7% | 121.8% |
| Net Margin | 730.0% | 170.0% | 173.7% | 121.8% |
| FCF Margin | — | — | — | — |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'25Latest | — | $3.23 | — | ||
| Q3'24 | — | $3.06 | — | ||
| Q2'24 | — | $8.08 | — | ||
| Q1'24 | — | $7.98 | — | ||
| Q4'23 | — | $-1.51 | — | ||
| Q3'23 | — | $5.86 | — | ||
| Q2'23 | — | $5.04 | — | ||
| Q1'23 | — | $6.25 | — |
Total return is +26.6% (1Y), outperforming the benchmark by +4.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +6.3% | -1.0% | — |
| 1Y | +26.6% | +4.3% | +11.7% |
| 3YCAGR | +23.5% | +4.6% | +34.1% |
| 5YCAGR | +13.3% | +2.3% | +42.4% |
| 10YCAGR | +10.9% | -2.1% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about General American Investors Company, Inc. (GAM) valuation, health, and returns.
General American Investors Company, Inc. is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Slightly cheap versus peers compared to industry peers. undervalued (implying +187.9% upside to DCF intrinsic value of $184.14)
General American Investors Company, Inc. has multiple valuation anchors: DCF Intrinsic Value: $184.14 | Peer Relative Fair Value: $75.99. A convergence of these signals offers higher conviction.
General American Investors Company, Inc. displays fair financial health with a composite quality score of 54/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 12.4%.
General American Investors Company, Inc. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
General American Investors Company, Inc.'s current growth trajectory is Accelerating. The company achieved +180.6% 1Y revenue growth and -36.1% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for General American Investors Company, Inc. include: -11.3% 1-year max drawdown. Volatility risk is characterized by a beta of 0.73x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.